Table 2.
Patients' EASI before and after the halometasone cream treatment.
| EASI Mean ± SD |
Total N = 60 |
Group A N = 28 |
Group B N = 17 |
Group C N = 15 |
P value |
|---|---|---|---|---|---|
| At enrollment (Day 0) | 30.7 ± 8.7 | 23.9 ± 4.2 | 33.9 ± 7.5 | 39.8 ± 4.9 | <0.0001 |
| Day 7 of the treatment | 18.4 ± 11.6 | 14.0 ± 7.0 | 18.2 ± 11.9 | 27.0 ± 13.81 | 0.001 |
| Day 14 of the treatment | 13.3 ± 10.8 | 9.9 ± 6.8 | 10.8 ± 10.1 | 22.3 ± 13.02 | <0.0001 |
| P value | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
EASI: eczema area and severity index. Repeated measures ANOVA was used to analyze the difference of the three groups. 1Significantly higher versus group B (P = 0.022) and group A (P < 0.0001). 2Significantly higher versus group B (P = 0.001) and group A (P < 0.0001).